A three-time-point method for assessing kinetic parameters of 64 Cu-labeled Ramucirumab trapping in VEGFR-2 positive lung tumors
Author:
Publisher
Elsevier BV
Subject
General Physics and Astronomy,Radiology, Nuclear Medicine and imaging,General Medicine,Biophysics
Reference12 articles.
1. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors;Wahl;J Nucl Med,2009
2. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung;Pajares;J Clin Oncol,2012
3. Ramucirumab (IMC-1121B): a novel attack on angiogenesis;Spratlin;Future Oncol,2010
4. PET imaging of VEGFR-2 expression in lung cancer with 64Cu-labeled Ramucirumab;Luo;J Nucl Med,2016
5. A method to quantify at late imaging a release rate of 18F-FDG in tissues;Laffon;CR Biol,2005
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Estimation of Cumulative Activity of 177Lu-Cetuximab from a Single Diagnostic 64Cu-Cetuximab Scan;Cancer Biotherapy and Radiopharmaceuticals;2022-06-01
2. Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma;Pharmaceuticals;2021-06-29
3. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy;Cancers;2021-03-03
4. Specific and Nonspecific Uptake in Quantitative 89Zr-Immuno-PET;Journal of Nuclear Medicine;2021-02-26
5. PET Imaging of Receptor Tyrosine Kinases in Cancer;Molecular Cancer Therapeutics;2018-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3